If youve been anywhere near the news lately, youve probably seen some truly terrifying headlines: Some Ozempic users are developing serious eye issues that lead to blindness (New York Post) Patients on Ozempic report waking up blind in as little as a day after using jab (The Scottish Sun) People taking weight-loss drugs say they are losing their sight
The Danish company, which was once Europes most valuable, sold the first FDA-approved GLP-1 injectable for weight loss, Wegovy
OSA requires treatment now
How Does the NIH Initiative to Prioritize Human-Based Research Affect Research Proposing the Use of Laboratory Animals
However, survey respondents indicated there were several different ways that patients reduced their GLP-1 doses, with 48% saying they took smaller injections than prescribed, 43% saying they split their doses over a longer period of time, 6% admitting using leftover medication from a friend or family member, and 1% indicating they used expired or leftover medication from a past prescription
The following conventional PCR program was used to RAPD markers: 5 min